Oppenheimer Remains a Buy on Alcon (ALC)
BofA Securities Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $108.83
Needham Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $110
Citi Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $112.23
Alcon Is Maintained at Buy by Needham
Alcon Analyst Ratings
Stifel Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $100
Bernstein Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $110.5
Alcon Downgraded to Hold From Buy at HSBC
Alcon (ALC) Receives a Buy From Stifel Nicolaus
BofA Securities Upgrades Alcon(ALC.US) to Buy Rating, Raises Target Price to $108.75
Positive Outlook for Alcon: Buy Rating Supported by Earnings Upgrade Cycle and Attractive Valuation
Needham Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $107
Alcon Price Target Maintained With a $107.00/Share by Needham
Alcon Analyst Ratings
Analysts' Top Healthcare Picks: NRX Pharmaceuticals (NRXP), Alcon (ALC)
Bernstein Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $110.5
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $112.3
Alcon (ALC) Gets a Buy From RBC Capital
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $103.26